Position
Fidelity in Adma Biologics, Inc.
Back to the book · All holders of ADMA
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark −$216.9K$9.01 → $8.37
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 302.2K | $5.51M | — | — | — | 0.0% |
| Q1 2026 | 338.9K | $3.05M | $9.01 | −$2.79M | $330.6K | 0.0% |
| Q2 2026 | 389.5K | $3.26M | $8.37 | −$216.9K | $423.3K | 0.0% |